Concepedia

R O Dillman

RO

15

Publications

1.4K

Citations

13

H-Index

1983

Active since

Affiliations

Hoag Memorial Hospital Presbyterian(Current)

University of California San Diego

Scripps Health

R O Dillman is an author at Hoag Memorial Hospital Presbyterian specializing in immunotherapy, immunology, and medicine.

Top concepts

Publications per year

1983–2001

15

Publications

15

Improved Survival in Stage III Non-Small-Cell Lung Cancer: Seven-Year Follow-up of Cancer and Leukemia Group B (CALGB) 8433 Trial

R O Dillman, James E. Herndon, Stephen L. Seagren et al. · JNCI Journal of the National Cancer Institute · 1996 · 931 citations · Full text

Recombinant Interleukin-2 and Adoptive Immunotherapy Alternated With Dacarbazine Therapy in Melanoma: A National Biotherapy Study Group Trial

R O Dillman, R. K. Oldham, Neil M. Barth et al. · JNCI Journal of the National Cancer Institute · 1990 · 72 citations

Toxicities and side effects associated with intravenous infusions of murine monoclonal antibodies.

R O Dillman, J Beauregard, Samuel E. Halpern et al. · PubMed · 1986 · 67 citations

, , +20

Monoclonal antibody KS1/4-methotrexate immunoconjugate studies in non-small cell lung carcinoma.

Darlene J. Elias, Lawrence E. Kline, Bruce A. Robbins et al. · American Journal of Respiratory and Critical Care Medicine · 1994 · 46 citations

, , +15

Monoclonal Antibody Therapy for Lymphoma

R O Dillman · Cancer Practice · 2001 · 45 citations

Rows per page

1–5 of 15